NON-SMALL LUNG CANCER

Clinical trials for NON-SMALL LUNG CANCER explained in plain language.

Never miss a new study

Get alerted when new NON-SMALL LUNG CANCER trials appear

Sign up with your email to follow new studies for NON-SMALL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

New hope for lung cancer patients when first targeted drug stops working

Disease control Not yet recruiting

This study looks at how well the drug taletrectinib works in people with advanced ROS1-positive non-small cell lung cancer whose cancer has gotten worse after treatment with entrectinib. Researchers will follow 50 patients in real-world clinics to see if the drug shrinks tumors a…

Matched conditions: NON-SMALL LUNG CANCER

Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control

Last updated Jun 27, 2026 07:52 UTC

NON-SMALL LUNG CANCER

Get alerted when new NON-SMALL LUNG CANCER trials appear

New hope for lung cancer patients when first targeted drug stops working